News

Bill & Melinda Gates’ Faith in CureVac is Leading to a New Program


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Bill & Melinda Gates’ Faith in CureVac is Leading to a New Program

 

Date: 07/08/2015


CureVac, a pioneer in the field of mRNA-based technology, today announced that the company has initiated its third target product development program in collaboration with the Bill & Melinda Gates Foundation.

The program will leverage CureVac’s RNActive technology platform in the development of a prophylactic vaccine to protect against respiratory syncytial virus (RSV), adding to the development programs previously initiated by CureVac and the Gates Foundation targeting mRNA vaccines for HIV and Rotavirus.

For more click here

Source: Labiotech

© Catalyst Innovation Portal 2019